Concepedia

Robert Zangerle

RZ

Statistics

Publications

27

Citations

2.4K

H-Index

21

Active since

1988

Affiliations

University College London(Current)

Inserm

Innsbruck Medical University

Rigshospitalet

Sorbonne Université

Robert Zangerle is an author at University College London specializing in antiretroviral therapy, hiv epidemiology, and infectious diseases.

Publications per year

1988–2023

27

Publications

27

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

Adam Trickey, Margaret May, Jörg Janne Vehreschild et al. · The Lancet HIV · 2017 · 1.1K citations · Full text

, , +11

Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery

Frederik Neess Engsig, Robert Zangerle, François Dabis et al. · Clinical Infectious Diseases · 2014 · 172 citations · Full text

, , +14

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2018 · 145 citations

, , +10

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy

Adam Trickey, Margaret May, Jörg Janne Vehreschild et al. · PLoS ONE · 2016 · 115 citations · Full text

, , +15

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2019 · 96 citations

, , +10

1–5 of 27